LONDON (Reuters) - AstraZeneca's board will be reviewing a sweetened takeover offer from Pfizer but the company has no further comment at this stage, a spokeswoman for the British drugmaker said on Friday. Earlier the U.S. drugmaker revealed it had raised its offer for the British group to 63 billion pounds ($106 billion). (Reporting by Ben Hirschler; editing by Kate Holton)
via Health News Headlines - Yahoo News http://ift.tt/1iJTyTk
via Health News Headlines - Yahoo News http://ift.tt/1iJTyTk
No comments:
Post a Comment